AeroNeph Therapeutics Announces Successful MBO and Global Search for Strategic Partners for Novel Renal Disease Drugs

AeroNeph Therapeutics (“AeroNeph”; www.aeronephtx.com), a pioneer in discovery of renal disease assets, has announced its MBO and corporate launch in the USA. BIRMINGHAM, ALABAMA, UK, September 12, 2022 /⁨EINPresswire.com⁩/ -- AeroNeph …